Literature DB >> 9426392

Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor.

D Liu1, I el-Hariry, A J Karayiannakis, J Wilding, R Chinery, W Kmiot, P D McCrea, W J Gullick, M Pignatelli.   

Abstract

Intestinal trefoil factor (TFF3) is a member of the trefoil family of peptides, which are constitutively expressed in the gastrointestinal tract. TFF3 has been shown to promote migration of intestinal epithelial cells in vitro and to enhance epithelial restitution in vivo. In the present study, we show that the stimulatory effect of TFF3 on the migration of HT29 colonic carcinoma cells requires the perturbation of E-cadherin function, a calcium-dependent cell-cell adhesion molecule in epithelia. A rapid (< 1 minute) and specific tyrosine phosphorylation of beta-catenin and epidermal growth factor receptor was detected in cells treated with recombinant rat TFF3. No phosphorylation of E-cadherin or alpha-catenin was detected. Tyrosine phosphorylation of beta-catenin was associated with reduced membranous E-cadherin expression, perturbation of intercellular adhesion, and promotion of cell motility. These results suggest that TFF3 enhances cell migration through modulation of E-cadherin/catenin complex function. Tyrosine phosphorylation of beta-catenin and epidermal growth factor receptor seems to be involved in this process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426392

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  41 in total

Review 1.  The role of the E-cadherin complex in gastrointestinal cell differentiation.

Authors:  R Del Buono; M Pignatelli
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

2.  The adenomatous polyposis coli tumour suppressor gene regulates c-MYC transcription in colon cancer cells.

Authors:  M Pignatelli
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 3.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

4.  Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation.

Authors:  T Kirchner; T Brabletz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

5.  The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation.

Authors:  D Taupin; D C Wu; W K Jeon; K Devaney; T C Wang; D K Podolsky
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

6.  The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin.

Authors:  Carol Wadham; Jennifer R Gamble; Mathew A Vadas; Yeesim Khew-Goodall
Journal:  Mol Biol Cell       Date:  2003-02-06       Impact factor: 4.138

7.  Intestinal trefoil factor confers colonic epithelial resistance to apoptosis.

Authors:  D R Taupin; K Kinoshita; D K Podolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

8.  Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.

Authors:  Thaer Khoury; Krishdeep Chadha; Milind Javle; Kathleen Donohue; Charles Levea; Renuka Iyer; Haruhiko Okada; Hiroki Nagase; Dongfeng Tan
Journal:  Int J Gastrointest Cancer       Date:  2005

9.  Trefoil factor 3 in perinatal pancreas is increased by gestational low protein diet and associated with accelerated β-cell maturation.

Authors:  Louise Winkel; Annika Bagge; Louise Larsen; Tobias N Haase; Morten Rasmussen; Jeanette Lykke; Dennis B Holmgaard; Lars Thim; Jens H Nielsen; Louise T Dalgaard
Journal:  Islets       Date:  2018-05-21       Impact factor: 2.694

10.  Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells.

Authors:  Joanna Nightingale; Khurram S Chaudhary; Paul D Abel; Andrew P Stubbs; Hanna M Romanska; Stephen E Mitchell; Gordon W H Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.